Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novus Therapeutics Inc (NVUS)

Novus Therapeutics Inc (NVUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novus Therapeutics Inc 19900 MACARTHUR BOULEVARD SUITE 550 IRVINE CA 92612 USA

novustherapeutics.com P: 949-238-8090

Description:

Novus Therapeutics, Inc. is a pharmaceutical company. It focused on the acquisition, development and commercialization of ear, nose and throat products. The company's platform consists of OP-01 Foam Platform and OP-02 Surfactant Program. Novus Therapeutics, Inc., formerly known as Tokai Pharmaceuticals Inc., is based in Irvine, United States.

Key Statistics

Overview:

Market Capitalization, $K 20,970
Shares Outstanding, K 1,436
Annual Sales, $ 0 K
Annual Net Income, $ -16,010 K
60-Month Beta 1.92
% of Insider Shareholders 2.20%
Float, K 1,405
% Float 97.80%

Growth:

1-Year Return 32.97%
3-Year Return -78.20%
5-Year Return -98.31%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/16/20
Earnings Per Share ttm -15.06
EPS Growth vs. Prev Qtr -44.93%
EPS Growth vs. Prev Year 1.18%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 10/05/20

NVUS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -133.49%
Return-on-Assets % -30.52%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.73
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar